The

carrying amount of goodwill was $

430

million and $

438

million at December 31, 2022 and 2021, respectively. The effect of foreign currency translation decreased goodwill by $

million.

The Company’s intangible assets included in the consolidated balance sheets are detailed as follows (dollars in thousands):



	December 31, 2022						December 31, 2021
	Gross Carrying Amount		Accumulated Amortization		Weighted- Average Amortization Period		Gross Carrying Amount		Accumulated Amortization		Weighted- Average Amortization Period
Capitalized software	$	589,604	$	441,414		5 years	$	575,658	$	420,862		5 years
Purchased intangibles		197,805		166,735		11 years		201,302		163,752		11 years
Trademarks		9,680		—		—		9,680		—		—
Licenses		14,070		6,729		6 years		12,635		6,199		7 years
Patents and other intangibles		104,139		73,021		8 years		102,353		68,414		8 years

Total	$	915,298	$	687,899		7 years	$	901,628	$	659,227		7 years

The

Company capitalized $54 million

$55

million and $68 million of intangible assets for the years ended December 31, 2022, 2021 and 2020, respectively. The gross carrying value of intangible assets and accumulated amortization for intangible assets decreased by $

40 million and $29 million, respectively, in the year ended December 31, 2022 due to the effects of foreign currency translation. Amortization expense for intangible assets was $58 million, $60 million and $57 million for the years ended December 31, 2022, 2021 and 2020, respectively. Amortization expense for intangible assets is estimated to be $61 million per year for each of the next five years.

During

2020, the Company recorded a

non-cash

charge of $

million for the impairment of certain intangible assets associated with its 2014 acquisition of Medimass due to a shift in strategic priorities. As a result, the Company reduced the gross carrying amount and accumulated amortization balances of its intangible assets by $

million and $

million,

respectively.